Startseite › Brustkrebs › Florida › Tampa
Klinische Studien zu Brustkrebs in Tampa, FL
43 Studien zu Brustkrebs suchen Teilnehmer an Standorten in und um Tampa (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Moffitt Cancer Center, Tampa
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Teilnehmer gesuchtPhase 1/2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
Study of AVZO-021 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Clinical Trial Site, Tampa
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Teilnehmer gesuchtPhase 1
- Moffitt, Tampa
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Teilnehmer gesuchtPhase 1
- Moffitt, Tampa
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center, Tampa
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center, Tampa
Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center-McKinley Campus, Tampa
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Teilnehmer gesuchtPhase 1
- Moffitt Cancer Center, Tampa
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center, Tampa
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Teilnehmer gesuchtPhase 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center, Tampa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Teilnehmer gesuchtPhase 2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
ILR to Prevent BRCL_MCC 23608
Teilnehmer gesucht
- Tampa General Hospital, Tampa
- Moffitt Cancer Center, Tampa
- University of South Florida, Tampa
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Teilnehmer gesuchtPhase 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
Teilnehmer gesuchtFrühe Phase 1
- Moffitt Cancer Center, Tampa
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Teilnehmer gesuchtBeobachtungsstudie
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
Teilnehmer gesuchtPhase 1
- Moffitt Cancer Center, Tampa
The MIND-BC Study: MIND Diet for Breast Cancer Cognition
Teilnehmer gesucht
- Moffitt Cancer Center, Tampa
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Teilnehmer gesuchtBeobachtungsstudie
- St. Joseph's Women's Hospital, Tampa
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Teilnehmer gesuchtPhase 1/2
- Moffitt Cancer Center, Tampa
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Tampa
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Teilnehmer gesuchtPhase 3
- Moffitt Cancer Center, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Exelixis Clinical Site #16, Tampa
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Teilnehmer gesuchtBeobachtungsstudie
- St. Joseph's Hospital - Baycare, Tampa
- University of South Florida, Tampa
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Teilnehmer gesuchtPhase 2
- Moffitt Cancer Center, Tampa
Brustkrebs-Studien in anderen Städten
- New York City, NY136 Studien
- Houston, TX126 Studien
- Boston, MA112 Studien
- Nashville, TN81 Studien
- Los Angeles, CA73 Studien
- Edison, NJ68 Studien
- St. Louis, MO64 Studien
- Queens, NY64 Studien
- Durham, NC64 Studien
- Chicago, IL59 Studien
- Philadelphia, PA56 Studien
- Dallas, TX55 Studien
Weitere Studien in Tampa
- Nichtkleinzelliges Lungenkarzinom51 Studien
- Krebs (alle Arten)39 Studien
- Kolorektales Karzinom34 Studien
- Akute myeloische Leukämie29 Studien
- Metastasierender Krebs29 Studien
- Lungenkrebs29 Studien
- Bauchspeicheldrüsenkrebs26 Studien
- Eierstockkrebs21 Studien
- Melanom19 Studien
- Myelodysplastische Syndrome19 Studien
- Prostatakrebs18 Studien
- Herzinsuffizienz18 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.